Psychometric Evaluation of the Facial and Total Vitiligo Area Scoring Index Instruments in the TRuE-V Phase 3 Studies by Kristen Bibeau, Kathleen Butler, Mingyue Wang, Konstantina Skaltsa, Iltefat H. Hamzavi

Connect to this object online.

Assessing Participants' Experiences with Vitiligo from Patient Interviews by Amit G. Pandya, Theresa Amoloja, Kristen Bibeau, Dana DiBenedetti, Katherine Kosa, Kathleen Butler, Deanna Kornacki, Khaled Ezzedine

Connect to this object online.

Baseline Levels of Circulating Inflammatory Biomarkers Stratify Patients with Vitiligo Who Significantly Repigment after Treatment with Ruxolitinib Cream by Michael D. Howell, Fiona I. Kuo, Beth Rumberger, Erika Boarder, Kang Sun, Kathleen Butler, John E. Harris, Pearl Grimes, David Rosmarin

Connect to this object online.

Safety and efficacy of ruxolitinib cream for the treatment of vitiligo: A randomised controlled trial secondary analysis at 3 years by John E. Harris, Amit G. Pandya, Mark Lebwohl, Iltefat H. Hamzavi, Pearl Grimes, Alice B. Gottlieb, Howard L. Sofen, Angela Y. Moore, Mingyue Wang, Deanna Kornacki, Kathleen Butler, David Rosmarin

Connect to this object online.